Image of the Day: Switch Gears
Sukanya Charuchandra | Sep 10, 2018
A gene responsible for the free-moving, primitive nature of fetal cells is expressed in some breast cancer cells in mice and humans.
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Drug Cocktail Slows Progress of Aggressive Breast Cancer
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Checkpoint inhibition combined with chemotherapy gives patients with triple-negative metastatic breast cancer about two months more time without significant tumor growth, a study finds.
Endocrinologist Ann Nardulli Dies
Kerry Grens | Jul 24, 2018
The University of Illinois professor studied the role of estrogen in breast cancer.
Image of the Day: New Kids on the Block
Sukanya Charuchandra | Jun 7, 2018
Researchers discover that a layer of human breast tissue is not one but two distinct cell types.
A T-Cell Tweak Combats Advanced Breast Cancer
Ashley Yeager | Jun 5, 2018
The immunotherapy eliminated a woman’s metastatic lesions and kept her disease-free for two years.
Wound-Healing in Mice Triggers Growth of Dormant Tumors
Jim Daley | Apr 12, 2018
Treating mice with anti-inflammatory drugs following surgery reduced the size of tumors.
Hundreds of Inherited Gene Variants Contribute to Cancer
Abby Olena | Apr 5, 2018
In the largest study of its kind to date, researchers find more than 850 rare, heritable genetic alterations that can predispose humans to cancer.
A Radical Intervention, 1894
Catherine Offord | Apr 1, 2018
William Halsted’s approach to mastectomy took the medical world by storm at the turn of the last century.
PARP Inhibitors Are Improving the Outlook of Hard-to-Treat Cancers
Vicki Brower | Apr 1, 2018
With three recent FDA approvals, and a number of Phase 3 trials ongoing, the drugs are seeing a surge in interest.
First Direct-to-Consumer BRCA Test Authorized by FDA
Kerry Grens | Mar 6, 2018
The agency gave personal genomics company 23andMe the green light to screen samples for breast cancer–related genetic mutations.